cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
Topic: Nanotechnology Applied to Overcome Tumor Drug Resistance

A special issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 30 Jun 2022

Guest Editor(s)

  • Prof. Xiang-Yang Shi
    College of Chemistry, Chemical Engineering and Biotechnology, Donghua Univeristy, Shanghai, China.

    Website | E-mail

Special Issue Introduction

Chemotherapy is one of the principal treatments for cancer patients in clinics. The chemotherapeutic drugs mostly present a satisfactory effect when they are first exposed to the cancer cells. However, drug resistance always emerges in these tumors. A range of nanodevices or nanostructures with multifunctionalities has been designed to overcome multidrug-resistant cancer cells. Strategies of blocking the drug transporters or inhibiting the expression of P-glycoprotein, integration of multiple drugs within nanomaterials, design of nanodrugs for the targeted killing of cancer stem cells, regulation of the tumor microenvironment, or relieving immunosuppression through nanotechnology-enabled approaches are promising to tackle multidrug resistance of cancer cells. This special issue will cover all aspects of nanotechnology-enabled approaches to treat multidrug-resistant cancer cells.

Submission Deadline

30 Jun 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=CDR211021
Submission Deadline: 30 Jun 2022
Contacts: Susan Song, Assistant Editor, Susan@cdrjournal.com

Published Articles

This special issue is now open for submission.
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties